How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy.

Falk Roeder (First author), Sabine Gerum (Co-author), Stefan Hecht (Co-author), Florian Huemer (Co-author), Tarkan Jäger (Co-author), Reinhard Kaufmann (Co-author), Eckhard Klieser (Co-author), Oliver Owen Koch (Co-author), Daniel Neureiter (Co-author), Klaus Emmanuel (Co-author), Felix Sedlmayer (Co-author), Richard Greil (Co-author), Lukas Weiss* (Last author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Citations (Web of Science)
Original languageEnglish
JournalCancers
Volume14
Issue number22
DOIs
Publication statusPublished - 2022

Keywords

  • CLINICAL COMPLETE RESPONSE
  • TOTAL MESORECTAL EXCISION
  • SHORT-COURSE RADIOTHERAPY
  • PREOPERATIVE CHEMORADIOTHERAPY
  • POSTOPERATIVE CHEMORADIOTHERAPY
  • PROGNOSTIC-SIGNIFICANCE
  • OPEN-LABEL
  • CHEMORADIATION
  • RECURRENCE
  • CHEMOTHERAPY

Cite this